|
|
|
Volumn 86, Issue 5 Suppl, 2010, Pages 16-25
|
|
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
AZELAIC ACID;
DERMATOLOGICAL AGENT;
DICARBOXYLIC ACID;
DOXYCYCLINE;
METRONIDAZOLE;
SULFACETAMIDE;
ARTICLE;
CLINICAL TRIAL;
DELAYED RELEASE FORMULATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PHASE 4 CLINICAL TRIAL;
ROSACEA;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
DELAYED-ACTION PREPARATIONS;
DERMATOLOGIC AGENTS;
DICARBOXYLIC ACIDS;
DOXYCYCLINE;
FEMALE;
HUMANS;
MALE;
METRONIDAZOLE;
MIDDLE AGED;
ROSACEA;
SEVERITY OF ILLNESS INDEX;
SULFACETAMIDE;
TREATMENT OUTCOME;
|
|
EID: 79952269390
PISSN: 00114162
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|
